Press Releases

Adocia , a biotech company specialized in the formulation of therapeutic proteins for the treatment of diabetes and chronic wounds, announces today that it has filed another three patent applications covering new formulations of monoclonal antibodies.  ...

Genzyme, a Sanofi company , and Isis Pharmaceuticals Inc. , announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 9 to 6 that Genzyme had provided sufficient efficacy...

NPS Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that the U.S. Food and Drug Administration’s (FDA) Gastrointestinal Drugs Advisory Committee voted unanimously to recommend approval of Gattex® (teduglutide)...

Vince & Associates Clinical Research announced today that it provided platinum sponsorship of the 6th Annual Pain Therapeutics Summit held October 3-4, 2012, in San Jose, Calif. The conference convened multidisciplinary industry colleagues to discuss...

Starting today, seniors and their caregiverscan stop by any Rite Aid pharmacy for a free personalized Medicare Part D consultation with a Rite Aid pharmacist or use Rite Aid's dedicated Medicare Advisor comparison tools online at www.riteaid.com. Appointments...

  Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the award of a EUR 1 million grant to support the Translate-MS-Repair...

Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms. The experimental medicines...